Study to Evaluate the Efficacy and Safety of Temozolomide in Subjects With Brain Metastases of Either Malignant Melanoma, Breast, or Non-small Cell Lung Cancer (P02064)
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastases of Central Nervous System|Melanoma|Breast Neoplasm|Carcinoma, Non-Small-Cell Lung
Interventions: DRUG: Temozolomide
Sponsor: Merck Sharp & Dohme LLC
Collaborators: Quintiles, Inc.